What was Vitalibis’s price range in the past 12 months?
Vitalibis lowest stock price was $0.03 and its highest was $2.00 in the past 12 months.
What is Vitalibis’s market cap?
Vitalibis’s market cap is $28.51M.
When is Vitalibis’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Vitalibis’s earnings last quarter?
Vitalibis released its earnings results on May 13, 2019. The company reported -$0.081 earnings per share for the quarter.
Is Vitalibis overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Vitalibis pay dividends?
Vitalibis does not currently pay dividends.
What is Vitalibis’s EPS estimate?
Vitalibis’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vitalibis have?
Vitalibis has 1,000,329,800 shares outstanding.
What happened to Vitalibis’s price movement after its last earnings report?
Vitalibis reported an EPS of -$0.081 in its last earnings report. Following the earnings report the stock price went same ―.
Which hedge fund is a major shareholder of Vitalibis?
Currently, no hedge funds are holding shares in VCBD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Vitalibis
Vitalibis, Inc. provides phytocannabinoid based hemp products with naturally occurring cannabidiol, personal care and nutritional products. The company was founded by Itzhak Ostashinsky on April 11, 2014 and is headquartered in Las Vegas, NV.
Sector
Financial
Industry
Pharmaceuticals
CEO
Steve Raack
Employees
1
Website
www.vitalibis.com
Address
3960 Howard Hughes Parkway,Suite 500, Las Vegas, NV, 89169, US